Skip to main content

Characteristics of New Opioid Use Among Medicare Beneficiaries: Identifying High-Risk Patterns.

Publication ,  Journal Article
Raman, SR; Bush, C; Karmali, RN; Greenblatt, LH; Roberts, AW; Skinner, AC
Published in: J Manag Care Spec Pharm
September 2019

BACKGROUND: Opioid prescription patterns, including long-term use, multiple prescribers, and high opioid doses, increase the risk for adverse outcomes; however, previous research in older adult populations has primarily described opioid dose patterns using average daily dose measures or using very high thresholds (i.e., > 100 morphine milligram equivalents [MME] per day). OBJECTIVE: To describe prescription patterns by peak dose among older adults who have newly initiated opioid use in 2014 and describe long-term opioid use and the use of multiple pharmacies and prescribers among those with peak opioid doses over 50 and over 90 MME per day. METHODS: This was a retrospective cohort study of Medicare Part D prescription claims data (5% sample) for beneficiaries aged 65 years and older who were prescribed ≥ 1 opioid prescription in 2014 and did not have an opioid prescription in the preceding 180 days. Within a 1-year period of follow-up, we used prescription claims to characterize individuals' opioid exposure, measuring long-term opioid use (≥ 90 days of continuous opioid supply), unique opioid prescribers, and unique opioid-dispensing pharmacies. Peak MME was defined as the maximum daily MME received across all overlapping opioid prescriptions in the observation period. RESULTS: 144,127 beneficiaries without an opioid prescription in the previous 6 months filled ≥ 1 opioid prescription in 2014. During the 1-year follow-up period, 6.5% of beneficiaries transitioned to long-term opioid use; 39.5% received opioid prescriptions from > 1 prescriber; 18.1% filled opioid prescriptions from > 1 pharmacy; and 21.8% had a peak MME of 50-89. Among the 28.1% of beneficiaries exposed to a peak MME > 50, 8.6% developed long-term opioid use; 7.0% had 3 or more opioid dispensing pharmacies; and 28.0% had 3 or more opioid prescribers. Among the 6.2% of beneficiaries exposed to a peak MME ≥ 90, 18.5% developed long-term opioid use; 13.0% had 3 or more opioid dispensing pharmacies; and 39.6% had 3 or more opioid prescribers. CONCLUSIONS: High doses of opioids were prescribed for about one quarter (28%) of Medicare beneficiaries with new opioid use in 2014. Having multiple opioid prescribers or multiple opioid dispensing pharmacies was common, especially among those prescribed higher doses. These prescription patterns can be particularly helpful to identify older adults with increased opioid-related risk. DISCLOSURES: No funding supported this study. Raman reports research grants from GlaxoSmithKline not related to this study. Roberts was supported by a CTSA grant from NCATS awarded to the University of Kansas Medical Center for Frontiers: The Heartland Institute for Clinical and Translational Research (#KL2TR000119). The other authors have no potential conflicts to report.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Manag Care Spec Pharm

DOI

EISSN

2376-1032

Publication Date

September 2019

Volume

25

Issue

9

Start / End Page

966 / 972

Location

United States

Related Subject Headings

  • United States
  • Retrospective Studies
  • Prescription Drug Misuse
  • Practice Patterns, Physicians'
  • Pharmacies
  • Pharmaceutical Services
  • Opioid-Related Disorders
  • Medicare
  • Male
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Raman, S. R., Bush, C., Karmali, R. N., Greenblatt, L. H., Roberts, A. W., & Skinner, A. C. (2019). Characteristics of New Opioid Use Among Medicare Beneficiaries: Identifying High-Risk Patterns. J Manag Care Spec Pharm, 25(9), 966–972. https://doi.org/10.18553/jmcp.2019.25.9.966
Raman, Sudha R., Christopher Bush, Ruchir N. Karmali, Lawrence H. Greenblatt, Andrew W. Roberts, and Asheley C. Skinner. “Characteristics of New Opioid Use Among Medicare Beneficiaries: Identifying High-Risk Patterns.J Manag Care Spec Pharm 25, no. 9 (September 2019): 966–72. https://doi.org/10.18553/jmcp.2019.25.9.966.
Raman SR, Bush C, Karmali RN, Greenblatt LH, Roberts AW, Skinner AC. Characteristics of New Opioid Use Among Medicare Beneficiaries: Identifying High-Risk Patterns. J Manag Care Spec Pharm. 2019 Sep;25(9):966–72.
Raman, Sudha R., et al. “Characteristics of New Opioid Use Among Medicare Beneficiaries: Identifying High-Risk Patterns.J Manag Care Spec Pharm, vol. 25, no. 9, Sept. 2019, pp. 966–72. Pubmed, doi:10.18553/jmcp.2019.25.9.966.
Raman SR, Bush C, Karmali RN, Greenblatt LH, Roberts AW, Skinner AC. Characteristics of New Opioid Use Among Medicare Beneficiaries: Identifying High-Risk Patterns. J Manag Care Spec Pharm. 2019 Sep;25(9):966–972.

Published In

J Manag Care Spec Pharm

DOI

EISSN

2376-1032

Publication Date

September 2019

Volume

25

Issue

9

Start / End Page

966 / 972

Location

United States

Related Subject Headings

  • United States
  • Retrospective Studies
  • Prescription Drug Misuse
  • Practice Patterns, Physicians'
  • Pharmacies
  • Pharmaceutical Services
  • Opioid-Related Disorders
  • Medicare
  • Male
  • Humans